A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)
RemeGen Co., Ltd.
RemeGen Co., Ltd.
RemeGen Co., Ltd.
RemeGen Co., Ltd.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
BeBetter Med Inc
Shandong Cancer Hospital and Institute
Second Affiliated Hospital of Soochow University
Jiangsu Cancer Institute & Hospital
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Jiangsu HengRui Medicine Co., Ltd.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Universitair Ziekenhuis Brussel
Martin-Luther-Universität Halle-Wittenberg
Jiangsu Simcere Pharmaceutical Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Czech Lymphoma Study Group
Assistance Publique - Hôpitaux de Paris
Beijing Hospital
Fudan University
Beijing Friendship Hospital
Fujian Medical University
Sun Yat-sen University
Instituto Nacional de Cancer, Brazil
Huazhong University of Science and Technology
Jilin University
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Tianjin Medical University Cancer Institute and Hospital
Hebei Medical University Fourth Hospital
Fudan University